Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States

被引：0
|
作者：
Mohamed I. Elsaid
You Li
Carolyn Catalano
Carlos D. Minacapelli
Kapil Gupta
Vinod K. Rustgi
机构：
[1] Rutgers Robert Wood Johnson Medical School,Division of Gastroenterology and Hepatology, Department of Medicine
[2] Rutgers Robert Wood Johnson Medical School,Center for Liver Diseases and Liver Masses
来源：
PharmacoEconomics - Open | 2021年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：89 / 100
页数：11
相关论文
共 50 条
  • [21] Real-World Healthcare Resource Utilization and Cost Burden Assessment for Adults With Generalized Myasthenia Gravis in the United States
    Phillips, Glenn
    Abreu, Catarina
    Goyal, Amit
    Li, Yuebing
    Whangbo, Albert
    Gelinas, Deborah
    Brauer, Edward
    Bhattacharya, Sankha
    FRONTIERS IN NEUROLOGY, 2022, 12
  • [22] The clinical outcomes and healthcare resource utilization in IgG4-related disease: a claims-based analysis of commercially insured adults in the United States
    Wallace, Zachary S.
    Miles, Gandarvaka
    Smolkina, Ekaterina
    Petruski-Ivleva, Natalia
    Madziva, Duane
    Guzzo, Krishan
    Cook, Claire
    Fu, Xiaoqing
    Zhang, Yuqing
    Stone, John H.
    Choi, Hyon K.
    RHEUMATOLOGY, 2024, 63 (09) : 2457 - 2466
  • [23] PREVALENCE AND COST OF ILLNESS OF SPECIFIC CONDITIONS IN A COMMERCIALLY INSURED UNITED STATES POPULATION
    Eisenberg, D.
    Sanchez, R. J.
    White, T. J.
    VALUE IN HEALTH, 2012, 15 (07) : A519 - A519
  • [24] Comorbidity Burden of Chronic Hepatitis B in a Commercially-insured Population in the United States
    Juday, Timothy
    Johnston, Stephen S.
    Wilson, Kathleen
    Quadri, Syed
    HEPATOLOGY, 2013, 58 : 624A - 624A
  • [25] ECONOMIC BURDEN OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN A COMMERCIALLY INSURED POPULATION IN THE UNITED STATES
    Oglesby, A. K.
    Durden, E.
    Narayanan, S.
    Juneau, P.
    Wilson, K.
    VALUE IN HEALTH, 2013, 16 (03) : A126 - A126
  • [26] The Burden of Hepatorenal Syndrome among Commercially-Insured and Medicare Patients in the United States
    Rice, J. B.
    White, Alan
    Galebach, Philip J.
    Korenblat, Kevin M.
    Wagh, Aneesha
    Lovelace, Belinda
    Wan, George J.
    Jamil, Khurram
    HEPATOLOGY, 2016, 64 : 1033A - 1034A
  • [27] Declining Use of Primary Care Among Commercially Insured Adults in the United States
    DeWitt, Dawn E.
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (02) : 166 - 166
  • [28] Anti-Obesity Medication Use in Commercially Insured Adults in the United States
    Kan, Hong
    Sacks, Naomi
    Chiu, Kevin
    Shinde, Shraddha
    Poon, Jiat Ling
    Ahmad, Nadia
    OBESITY, 2020, 28 : 49 - 49
  • [29] BURDEN OF HEPATIC ENCEPHALOPATHY AMONG PATIENTS IN A COMMERCIALLY-INSURED POPULATION IN THE UNITED STATES
    Rice, J. Bradford
    White, Alan
    Johnson, Michaels
    Simes, Mark
    Zuckerman, Peter
    Berman, Richard
    Hovland, Sara
    Huang, Xingyue
    HEPATOLOGY, 2020, 72 : 1059 - 1059
  • [30] Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis
    Placzek, Hilary
    Xu, Yaping
    Mu, Yunming
    Begelman, Susan M.
    Fisher, Maxine
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (12): : 1106 - +
12345